Literature DB >> 11839592

Inducible expression of vascular endothelial growth factor in adult mice causes severe proliferative retinopathy and retinal detachment.

Kyoko Ohno-Matsui1, Akira Hirose, Satoru Yamamoto, Jina Saikia, Naoyuki Okamoto, Peter Gehlbach, Elia J Duh, Sean Hackett, Michelle Chang, Dean Bok, Donald J Zack, Peter A Campochiaro.   

Abstract

Transgenic mice with vascular endothelial growth factor (VEGF) driven by the rhodopsin promoter (rho/VEGF mice) develop neovascularization that originates from the deep capillary bed of the retina and grows into the subretinal space. In rho/VEGF mice, VEGF expression in photoreceptors begins between postnatal days 5 and 7, the period when the deep capillary bed is developing. An important question is whether or not the developmental stage of the deep capillary bed is critical for occurrence of neovascularization. Also, although rho/VEGF mice are extremely useful for the study of ocular neovascularization, there are some applications for which the early onset of VEGF expression is a disadvantage. In this study, we used the reverse tetracycline transactivator (rtTA) inducible promoter system coupled to either the rhodopsin or interphotoreceptor retinoid-binding protein (IRBP) promoter to control the time of onset of VEGF transgene expression in photoreceptors. In the absence of doxycycline, adult double-transgenic rho/rtTA-TRE/VEGF or IRBP/rtTA-TRE/VEGF mice showed little VEGF transgene expression and no phenotype. The addition of doxycycline to the drinking water resulted in prominent transgene expression and evidence of neovascularization within 3 to 4 days. Like rho/VEGF mice, the neovascularization originated from the deep capillary bed of the retina, but it was more extensive and caused outer retinal folds followed by total retinal detachment. Real-time polymerase chain reaction and enzyme-linked immunosorbent assay demonstrated that the mice with inducible expression of VEGF that developed retinal detachment had much higher ocular levels of VEGF mRNA and protein compared to rho/VEGF mice that manifest a much milder phenotype. These data demonstrate that regardless of developmental stage of the vascular bed, increased expression of VEGF in the retina is sufficient to cause neovascularization, and high levels of expression cause severe neovascularization and traction retinal detachment. Mice with inducible expression of VEGF in the retina provide a valuable new model of ocular neovascularization.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11839592      PMCID: PMC1850637          DOI: 10.1016/S0002-9440(10)64891-2

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  26 in total

1.  Retinal VEGF mRNA measured by SYBR green I fluorescence: A versatile approach to quantitative PCR.

Authors:  D A Simpson; S Feeney; C Boyle; A W Stitt
Journal:  Mol Vis       Date:  2000-10-05       Impact factor: 2.367

2.  Tetracycline-inducible system for photoreceptor-specific gene expression.

Authors:  M A Chang; J W Horner; B R Conklin; R A DePinho; D Bok; D J Zack
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-12       Impact factor: 4.799

3.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

4.  Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy.

Authors:  A P Adamis; J W Miller; M T Bernal; D J D'Amico; J Folkman; T K Yeo; K T Yeo
Journal:  Am J Ophthalmol       Date:  1994-10-15       Impact factor: 5.258

5.  Dramatic inhibition of retinal and choroidal neovascularization by oral administration of a kinase inhibitor.

Authors:  M S Seo; N Kwak; H Ozaki; H Yamada; N Okamoto; E Yamada; D Fabbro; F Hofmann; J M Wood; P A Campochiaro
Journal:  Am J Pathol       Date:  1999-06       Impact factor: 4.307

6.  Blockade of vascular endothelial cell growth factor receptor signaling is sufficient to completely prevent retinal neovascularization.

Authors:  H Ozaki; M S Seo; K Ozaki; H Yamada; E Yamada; N Okamoto; F Hofmann; J M Wood; P A Campochiaro
Journal:  Am J Pathol       Date:  2000-02       Impact factor: 4.307

7.  Pigment epithelium-derived factor inhibits retinal and choroidal neovascularization.

Authors:  K Mori; E Duh; P Gehlbach; A Ando; K Takahashi; J Pearlman; K Mori; H S Yang; D J Zack; D Ettyreddy; D E Brough; L L Wei; P A Campochiaro
Journal:  J Cell Physiol       Date:  2001-08       Impact factor: 6.384

8.  Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis.

Authors:  D Shweiki; A Itin; D Soffer; E Keshet
Journal:  Nature       Date:  1992-10-29       Impact factor: 49.962

9.  Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo.

Authors:  K H Plate; G Breier; H A Weich; W Risau
Journal:  Nature       Date:  1992-10-29       Impact factor: 49.962

10.  Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model.

Authors:  J W Miller; A P Adamis; D T Shima; P A D'Amore; R S Moulton; M S O'Reilly; J Folkman; H F Dvorak; L F Brown; B Berse
Journal:  Am J Pathol       Date:  1994-09       Impact factor: 4.307

View more
  62 in total

Review 1.  Animal models of age related macular degeneration.

Authors:  Mark E Pennesi; Martha Neuringer; Robert J Courtney
Journal:  Mol Aspects Med       Date:  2012-06-15

Review 2.  The mouse retina as an angiogenesis model.

Authors:  Andreas Stahl; Kip M Connor; Przemyslaw Sapieha; Jing Chen; Roberta J Dennison; Nathan M Krah; Molly R Seaward; Keirnan L Willett; Christopher M Aderman; Karen I Guerin; Jing Hua; Chatarina Löfqvist; Ann Hellström; Lois E H Smith
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-06       Impact factor: 4.799

3.  Long-term expression of glial cell line-derived neurotrophic factor slows, but does not stop retinal degeneration in a model of retinitis pigmentosa.

Authors:  Masayuki Ohnaka; Katsuaki Miki; Yuan-Yuan Gong; Rebecca Stevens; Takeshi Iwase; Sean F Hackett; Peter A Campochiaro
Journal:  J Neurochem       Date:  2012-07-23       Impact factor: 5.372

4.  In Vitro Angiogenesis Effect of Xuefu Zhuyu Decoction () and Vascular Endothelial Growth Factor: A Comparison Study.

Authors:  Fan Lin; Bin-Ling Chen; Yi-Zheng Wang; Dong Gao; Jun Song; T J Kaptchuk; Ke-Ji Chen
Journal:  Chin J Integr Med       Date:  2015-08-14       Impact factor: 1.978

5.  Long-term global retinal microvascular changes in a transgenic vascular endothelial growth factor mouse model.

Authors:  W-Y Shen; C M Lai; C E Graham; N Binz; Y K Y Lai; J Eade; D Guidolin; D Ribatti; S A Dunlop; P E Rakoczy
Journal:  Diabetologia       Date:  2006-05-10       Impact factor: 10.122

6.  Generation of transgenic mice with mild and severe retinal neovascularisation.

Authors:  C-M Lai; S A Dunlop; L A May; M Gorbatov; M Brankov; W-Y Shen; N Binz; Y Ky Lai; C E Graham; C J Barry; I J Constable; L D Beazley; E P Rakoczy
Journal:  Br J Ophthalmol       Date:  2005-07       Impact factor: 4.638

7.  Increased ocular levels of IGF-1 in transgenic mice lead to diabetes-like eye disease.

Authors:  Jesús Ruberte; Eduard Ayuso; Marc Navarro; Ana Carretero; Víctor Nacher; Virginia Haurigot; Mónica George; Cristina Llombart; Alba Casellas; Cristina Costa; Assumpció Bosch; Fatima Bosch
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

8.  Anisotropic poly(lactic-co-glycolic acid) microparticles enable sustained release of a peptide for long-term inhibition of ocular neovascularization.

Authors:  Jayoung Kim; Raquel Lima E Silva; Ron B Shmueli; Adam C Mirando; Stephany Y Tzeng; Niranjan B Pandey; Elana Ben-Akiva; Aleksander S Popel; Peter A Campochiaro; Jordan J Green
Journal:  Acta Biomater       Date:  2019-07-30       Impact factor: 8.947

9.  Increased expression of catalase and superoxide dismutase 2 reduces cone cell death in retinitis pigmentosa.

Authors:  Shinichi Usui; Keiichi Komeima; Sun Young Lee; Young-Joon Jo; Shinji Ueno; Brian S Rogers; Zhihao Wu; Jikui Shen; Lili Lu; Brian C Oveson; Peter S Rabinovitch; Peter A Campochiaro
Journal:  Mol Ther       Date:  2009-03-17       Impact factor: 11.454

10.  An Adam15 amplification loop promotes vascular endothelial growth factor-induced ocular neovascularization.

Authors:  Bing Xie; Jikui Shen; Aling Dong; Mara Swaim; Sean F Hackett; Lorenza Wyder; Susanne Worpenberg; Samuel Barbieri; Peter A Campochiaro
Journal:  FASEB J       Date:  2008-04-01       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.